#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Castleman's disease Congenital ectodermal dysplasia Liver transplant rejection Fragile X syndrome Neoplasm Glomerulonephritis acute Fabry's disease Fungal infection Synovial sarcoma Cutaneous T-cell lymphoma refractory Epstein-Barr virus associated lymphoproliferative disorder Pulmonary alveolar haemorrhage Hypersomnia Conjunctivitis allergic Squamous cell carcinoma of head and neck More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome Activated PI3 kinase delta syndrome – Life with Disease Familial haemophagocytic lymphohistiocytosis – Life with Disease Marginal zone lymphoma refractory Medulloblastoma – Treatment Noonan syndrome – Basic Information Skin angiosarcoma – Life with Disease Epidermolysis bullosa – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics Pulmonary sarcoidosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Casirivimab Gemlapodect Gelatin Mk-1200 VINBLASTINE Gad20-209-Fsp-A2 VTX2735 SODIUM GOCATAMIG Modafinil Aptamer-4Ft Quavonlimab Ecoo25B Paclitaxel F770/05 JX10 Volixibat Mps-103 Carisbamate Sodium Glycerophosphate Pivmecillinam Hydrochloride More therapies…

    Learn about Your Condition

    Acne Testicular leiomyosarcoma Sickle cell anaemia Oropharyngeal cancer Epstein-Barr virus infection Short stature Stomatitis Hyponatraemia Procedural anxiety Progressive supranuclear palsy Muscle spasticity Hypertrophic scar Lung neoplasm malignant Nocturia Allergic respiratory disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Indocyanine Green and Near-Infrared Fluorescence for Lymph Node Removal in Children with Renal Tumours or Paratesticular Rhabdomyosarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Indocyanine Green
    The Netherlands

  • A study to assess the safety and effectiveness of GXV813 in hospitalized adults with schizophrenia

    Recruiting

    2 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • GXV813
    Bulgaria

  • A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis

    Recruiting

    1 1
    Investigated Drugs:
    • MB-001
    Poland

  • A study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease

    Recruiting

    3 1
    Belgium France Germany Italy The Netherlands Poland +2

  • Comparing the efficacy and safety of KAI-9531 and semaglutide in people living with obesity who do not have diabetes

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • HRS 9531
    • Semaglutide
    Bulgaria Poland

  • Comparing RO7771950 with a drug combination of tucatinib, trastuzumab, and capecitabine in patients with HER2-positive metastatic or locally advanced breast cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • (R)-N-(4-([1,2,4]-TRIAZOLO[1,5-C]-PYRIMIDIN-7-YLOXY)-3-METHYLPHENYL)-5-((3,3-DIFLUORO-1-METHYLPIPERIDIN-4-YL)OXY)-6-METHOXYQUINAZOLIN-4-AMINE
    • Tucatinib
    • Capecitabine
    Austria Belgium Czechia France Germany Hungary +5
Previous Page
1 … 21 22 23 24 25 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!